早期子宫颈癌保留生育功能手术的中国专家共识

2021-08-17 中国医师协会微无创医学专业委员会妇科肿瘤中国微创外科杂志. 2021,21(08)

自1987年Dargent创立广泛子宫颈切除术（radical trachelectomy, RT）以来,早期子宫颈癌年轻患者的保留生育功能手术（fertility-sparing surgery,

中文标题：

发布机构：

中国医师协会微无创医学专业委员会妇科肿瘤

发布日期：

2021-08-17

简要介绍：

自1987年Dargent创立广泛子宫颈切除术（radical trachelectomy, RT）以来,早期子宫颈癌年轻患者的保留生育功能手术（fertility-sparing surgery, FSS）快速发展,已经形成以Dargent术式——腹腔镜辅助经阴道广泛子宫颈切除术（laparoscopic-assisted vaginal radical trachelectomy, LAVRT/VRT）为经典.

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=068031c00216a5f3, title=早期子宫颈癌保留生育功能手术的中国专家共识 , enTitle=, guiderFrom=中国微创外科杂志. 2021,21(08), authorId=0, author=, summary=自1987年Dargent创立广泛子宫颈切除术（radical trachelectomy, RT）以来,早期子宫颈癌年轻患者的保留生育功能手术（fertility-sparing surgery, , cover=https://img.medsci.cn/2021829/1630242119115_2020535.jpg, journalId=0, articlesId=null, associationId=1952, associationName=中国医师协会微无创医学专业委员会妇科肿瘤, associationIntro=中国医师协会微无创医学专业委员会妇科肿瘤(学组)专业委员会, copyright=0, guiderPublishedTime=Tue Aug 17 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">自1987年Dargent创立广泛子宫颈切除术（radical trachelectomy, RT）以来,早期子宫颈癌年轻患者的保留生育功能手术（fertility-sparing surgery, FSS）快速发展,已经形成以Dargent术式——腹腔镜辅助经阴道广泛子宫颈切除术（laparoscopic-assisted vaginal radical trachelectomy, LAVRT/VRT）为经典.</span></p>, tagList=[TagDto(tagId=18201, tagName=子宫颈癌)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21053, categoryName=梅斯医学-宫颈癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=18201, guiderKeyword=子宫颈癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1920, appHits=91, showAppHits=0, pcHits=247, showPcHits=1829, likes=2, shares=12, comments=8, approvalStatus=1, publishedTime=Sun Aug 29 22:36:28 CST 2021, publishedTimeString=2021-08-17, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 29 21:02:59 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 13:16:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=早期子宫颈癌保留生育功能手术的中国专家共识_熊光武.pdf)])

早期子宫颈癌保留生育功能手术的中国专家共识_熊光武.pdf

下载请点击：

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1077176, encodeId=c46010e7176ad, content=喜欢该共识，受益非浅 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Sun Dec 05 22:55:36 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077175, encodeId=6ddd10e7175df, content=喜欢该共识，为我们临床医生提供帮助 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Sun Dec 05 22:53:21 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072556, encodeId=00af10e255606, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Sun Nov 21 17:05:30 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059613, encodeId=a4621059613d1, content=收益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7995632374, createdName=Arwen_Lau, createdTime=Mon Oct 11 23:26:00 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056191, encodeId=374d1056191e1, content=耳目一新！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Wed Sep 29 18:47:42 CST 2021, time=2021-09-29, status=1, ipAttribution=)]
2021-12-05 ms4000001291803254

喜欢该共识，受益非浅

48 0
[GetPortalCommentsPageByObjectIdResponse(id=1077176, encodeId=c46010e7176ad, content=喜欢该共识，受益非浅 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Sun Dec 05 22:55:36 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077175, encodeId=6ddd10e7175df, content=喜欢该共识，为我们临床医生提供帮助 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Sun Dec 05 22:53:21 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072556, encodeId=00af10e255606, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Sun Nov 21 17:05:30 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059613, encodeId=a4621059613d1, content=收益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7995632374, createdName=Arwen_Lau, createdTime=Mon Oct 11 23:26:00 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056191, encodeId=374d1056191e1, content=耳目一新！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Wed Sep 29 18:47:42 CST 2021, time=2021-09-29, status=1, ipAttribution=)]
2021-12-05 ms4000001291803254

喜欢该共识，为我们临床医生提供帮助

47 0
[GetPortalCommentsPageByObjectIdResponse(id=1077176, encodeId=c46010e7176ad, content=喜欢该共识，受益非浅 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Sun Dec 05 22:55:36 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077175, encodeId=6ddd10e7175df, content=喜欢该共识，为我们临床医生提供帮助 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Sun Dec 05 22:53:21 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072556, encodeId=00af10e255606, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Sun Nov 21 17:05:30 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059613, encodeId=a4621059613d1, content=收益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7995632374, createdName=Arwen_Lau, createdTime=Mon Oct 11 23:26:00 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056191, encodeId=374d1056191e1, content=耳目一新！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Wed Sep 29 18:47:42 CST 2021, time=2021-09-29, status=1, ipAttribution=)]
2021-11-21 ms3000001592172450

受益匪浅

55 0
[GetPortalCommentsPageByObjectIdResponse(id=1077176, encodeId=c46010e7176ad, content=喜欢该共识，受益非浅 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Sun Dec 05 22:55:36 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077175, encodeId=6ddd10e7175df, content=喜欢该共识，为我们临床医生提供帮助 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Sun Dec 05 22:53:21 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072556, encodeId=00af10e255606, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Sun Nov 21 17:05:30 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059613, encodeId=a4621059613d1, content=收益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7995632374, createdName=Arwen_Lau, createdTime=Mon Oct 11 23:26:00 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056191, encodeId=374d1056191e1, content=耳目一新！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Wed Sep 29 18:47:42 CST 2021, time=2021-09-29, status=1, ipAttribution=)]
2021-10-11 Arwen_Lau

收益了

59 0
[GetPortalCommentsPageByObjectIdResponse(id=1077176, encodeId=c46010e7176ad, content=喜欢该共识，受益非浅 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Sun Dec 05 22:55:36 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077175, encodeId=6ddd10e7175df, content=喜欢该共识，为我们临床医生提供帮助 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62206167433, createdName=ms4000001291803254, createdTime=Sun Dec 05 22:53:21 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072556, encodeId=00af10e255606, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Sun Nov 21 17:05:30 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059613, encodeId=a4621059613d1, content=收益了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7995632374, createdName=Arwen_Lau, createdTime=Mon Oct 11 23:26:00 CST 2021, time=2021-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056191, encodeId=374d1056191e1, content=耳目一新！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Wed Sep 29 18:47:42 CST 2021, time=2021-09-29, status=1, ipAttribution=)]
2021-09-29 ms3000001592172450

耳目一新！

50 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

妇产科指南

早期子宫颈癌保留生育功能手术的中国专家共识

相关指南

拓展阅读

科室

工具

服务